Mast cells recruitment to malignant pleural effusions

C. A. Kairi, S. P. Karabela, C. Moschos, S. Magkouta, I. Psallidas, C. Roussos, S. G. Zakynthinos, I. Kalomenidis, G. T. Stathopoulos (Greece)

Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Session: Current issues in malignant pleural diseases
Session type: Thematic Poster Session
Number: 3314
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. A. Kairi, S. P. Karabela, C. Moschos, S. Magkouta, I. Psallidas, C. Roussos, S. G. Zakynthinos, I. Kalomenidis, G. T. Stathopoulos (Greece). Mast cells recruitment to malignant pleural effusions. Eur Respir J 2010; 36: Suppl. 54, 3314

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC Abstract – A requirement for mast cells in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015

Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007



Utility of significant number of mesothelial cells in tuberculous pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 426s
Year: 2004

Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006

Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019



The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma?
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012


Interleukin-16 in tuberculous and malignant pleural effusions
Source: Eur Respir J 2005; 25: 605-611
Year: 2005



Pleurodesis for malignant pleural effusion
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Pleurodesis for malignant pleural effusion
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Usfulness of cholesterol in difering malignant and nonmalignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004

Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010